Evidence map›Paper›PMID 26274499›Full record

ArticlePloS one2015

Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology.

Tess V Clendenen, Justin Rendleman, Wenzhen Ge, Karen L Koenig, Isaac Wirgin, Diane Currie, Roy E Shore, Tomas Kirchhoff, Anne Zeleniuch-Jacquotte

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Tess V ClendenenDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Justin RendlemanDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Wenzhen GeDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Karen L KoenigDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Isaac WirginDepartment of Environmental Medicine, New York University School of Medicine, New York, New York, United States of America.
Diane CurrieDepartment of Environmental Medicine, New York University School of Medicine, New York, New York, United States of America.
Roy E ShoreDepartment of Environmental Medicine, New York University School of Medicine, New York, New York, United States of America; Radiation Effects Research Foundation, Hiroshima Japan.
Tomas KirchhoffDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America.
Anne Zeleniuch-JacquotteDepartment of Population Health, New York University School of Medicine, New York, New York, United States of America; NYU Cancer Institute, New York University Langone Medical Center, New York, New York, United States of America.
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Vitamin D, Related Genes and Breast Cancer RiskR01CA098661 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JAQUOTTE, ANNE · 2003 to 2013
$9.7M
The NYU Women's Health StudyUM1CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JAQUOTTE, ANNE · 2015 to 2019
$3.7M
Estrogen Metabolism Related Genes &Endometrial CancerR01CA081212 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JACQUOTTE, ANNE · 1999 to 2007
$995k
NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA081212NCI NIH HHS R01 CA098661NCI NIH HHS UM1 CA182934NIEHS NIH HHS ES000260NIEHS NIH HHS P30 ES000260
6 · The paper itself

Abstract

backgroundLarge epidemiologic studies have the potential to make valuable contributions to the assessment of gene-environment interactions because they prospectively collected detailed exposure data. Some of these studies, however, have only serum or plasma samples as a low quantity source of DNA.

methodsWe examined whether DNA isolated from serum can be used to reliably and accurately genotype single nucleotide polymorphisms (SNPs) using Sequenom multiplex SNP genotyping technology. We genotyped 81 SNPs using samples from 158 participants in the NYU Women's Health Study. Each participant had DNA from serum and at least one paired DNA sample isolated from a high quality source of DNA, i.e. clots and/or cell precipitates, for comparison.

resultsWe observed that 60 of the 81 SNPs (74%) had high call frequencies (≥95%) using DNA from serum, only slightly lower than the 85% of SNPs with high call frequencies in DNA from clots or cell precipitates. Of the 57 SNPs with high call frequencies for serum, clot, and cell precipitate DNA, 54 (95%) had highly concordant (>98%) genotype calls across all three sample types. High purity was not a critical factor to successful genotyping.

conclusionsOur results suggest that this multiplex SNP genotyping method can be used reliably on DNA from serum in large-scale epidemiologic studies.

Indexed as

Polymorphism, Single NucleotideAdultAgedDNAFemaleGenotyping TechniquesHigh-Throughput Nucleotide SequencingHumansMiddle AgedProspective StudiesDNA

Identifiers

PMID26274499
PMCPMC4537187
OpenAlexW1908241373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.